Corcept Therapeutics | Umsatzkosten



Cost Of Sales Veränderung Datum
Acadia Pharmaceuticals USD 20.39M 1.41M 2025-03
Alaunos Therapeutics 0 18K 2024-09
ANI Pharmaceuticals USD 73.04M 7.24M 2025-03
Ardelyx USD 18.26M 2.54M 2024-12
Aurora Cannabis CAD 78.85M 891K 2024-12
BioMarin Pharmaceutical USD 151.56M 15.42M 2025-03
Bristol-Myers Squibb USD 3.03B 179M 2025-03
Canopy Growth CAD 50.66M 9.51M 2024-12
Corcept Therapeutics USD 2.4M 553K 2025-03
Eli Lilly USD 2.22B 179.6M 2025-03
J&J USD 7.3B 189M 2025-03
Knight Therapeutics CAD 47.25M 990K 2024-09
Merck USD 2.76B 944M 2025-03
Novartis USD 3.32B 90M 2024-12
Novartis USD 3.31B 73M 2024-12
Pacira USD 34.31M 5.58M 2025-03
Pfizer USD 2.59B 3.06B 2025-03
Supernus Pharmaceuticals USD 17.2M 385K 2024-12
TG Therapeutics USD 15.4M 6.06M 2024-12



Corcept Therapeutics Umsatzkosten - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - May 2025.